EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 I

Ensembl ID : ENSG00000100346
Gene: CACNA1I
Gene Synonyms: CAV3.3
8 APIs:
7 Enzyme and pathways 8 Cross references
195 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Subunit Alpha1 S

Ensembl ID : ENSG00000081248
Gene: CACNA1S
Gene Synonyms: CACNL1A3,CAV1.1,HOKPP,HYPOPP,MHS5
32 APIs:
5 Enzyme and pathways 8 Cross references
266 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Cannabinoid Receptor 1

Ensembl ID : ENSG00000118432
Gene: CNR1
Gene Synonyms: CANN6,CB-R,CB1,CB1A,CB1K5,CNR
13 APIs:
6 Enzyme and pathways 7 Cross references
207 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Cannabinoid Receptor 2

Ensembl ID : ENSG00000188822
Gene: CNR2
Gene Synonyms: CB2
8 APIs:
6 Enzyme and pathways 7 Cross references
196 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase 1

Ensembl ID : ENSG00000133742
Gene: CA1
Gene Synonyms: CAR1
8 APIs:
12 Enzyme and pathways 7 Cross references
288 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase 12

Ensembl ID : ENSG00000074410
Gene: CA12
Gene Synonyms: HST18816
5 APIs:
2 Enzyme and pathways 8 Cross references
215 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase 13

Ensembl ID : ENSG00000185015
Gene: CA13
Gene Synonyms: CAXIII,FLJ37995,MGC59868
2 APIs:
2 Enzyme and pathways 7 Cross references
291 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase 14

Ensembl ID : ENSG00000118298
Gene: CA14
Gene Synonyms:
2 APIs:
2 Enzyme and pathways 7 Cross references
210 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase 2

Ensembl ID : ENSG00000104267
Gene: CA2
Gene Synonyms: CA-II,CAII,CAR2
10 APIs:
6 Enzyme and pathways 8 Cross references
285 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase 3

Ensembl ID : ENSG00000164879
Gene: CA3
Gene Synonyms: CAIII,CAR3
2 APIs:
2 Enzyme and pathways 7 Cross references
310 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase 4

Ensembl ID : ENSG00000167434
Gene: CA4
Gene Synonyms: CAIV,CAR4,RP17
7 APIs:
6 Enzyme and pathways 7 Cross references
334 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Carbonic Anhydrase 5a

Ensembl ID : ENSG00000174990
Gene: CA5A
Gene Synonyms: CA5,CAV,CAVA
2 APIs:
2 Enzyme and pathways 9 Cross references
170 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).